Intellectual Property India Publishes Patent Application for 'Development Of Carbohydrate-Based Anti-Salmonella Vaccines' Filed by Board Of Trustees Of Michigan State University; and University Of Maryland, Baltimore

MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517015085 A) filed by Board Of Trustees Of Michigan State University; and University Of Maryland, Baltimore, East Lansing, U.S.A., on Feb. 21, for 'development of carbohydrate-based anti-salmonella vaccines.'

Inventor(s) include Huang, Xuefei; Pan, Xingling; Huo, Chang-Xin; Baliban, Scott Michael; and Tennant, Sharon Mei.

The application for the patent was published on May 30, under issue no. 22/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are vaccine composition comprising a Salmonella antigen conjugated to a capsid, wherein the capsid comprises wild type or native sequence. Provided herein are also vaccine composition comprising a Salmonella antigen conjugated to a capsid, wherein said capsid comprises at least one mutation, such as a non-natural mutation. Such compositions are useful in the treatment and prevention of preventing or treating a Salmonella infection (salmonellosis), gastroenteritis, typhoid fever, and/or paratyphoid fever; and may be effective against multiple strains of Salmonella."

The patent application was internationally filed on July 26, 2023, under International application No.PCT/US2023/028672.

Disclaimer: Curated by HT Syndication.